<DOC>
	<DOCNO>NCT00565916</DOCNO>
	<brief_summary>Estrogen progesterone two main female sex hormone . When woman go menopause , body 's production estrogen progesterone significantly decrease . Recent study show breakdown fatty acid cardiac muscle important maintain healthy heart , estrogen may enhance process . Also , cardiovascular disease ( CVD ) occur frequently postmenopausal woman premenopausal woman . This study determine postmenopausal woman whether estrogen increase heart 's ability use fat energy whether progesterone decrease effect .</brief_summary>
	<brief_title>Evaluating Roles Estrogen Progesterone Heart Metabolism</brief_title>
	<detailed_description>Menopause natural event generally occur woman age 45 55 . During menopause , body start produce less estrogen progesterone menstruation eventually stop . Estrogen progesterone involve many important function woman 's body , drastic decline hormone menopause lead significant change body . Along change , postmenopausal woman high risk premenopausal woman certain health problem , CVD . Previous study reveal alteration breakdown fatty acid cardiac muscle play key role variety cardiac disorder . In study involve human skeletal muscle , estrogen show increase breakdown fatty acid , progesterone lessens effect . This study determine postmenopausal woman whether estrogen increase heart 's ability break fat energy use whether progesterone decrease effect . This study also analyze ovariectomized mouse determine candidate specific estrogen receptor modulators ( SERMs ) raloxifene tamoxifen increase heart 's ability use fat energy whether increase similar see estrogen . Study investigator also create estrogen receptor knock-out mouse ( mice estrogen receptor remove ) explore role estrogen SERMs heart metabolism . Participation double-blind study last 1 month include three study visit . During Visit 1 , participant undergo three standard clinical evaluation . The first evaluation , medical screening , include medical history exam blood test measure estrogen progesterone level , liver kidney function , cholesterol level , blood sugar insulin level . For second evaluation , participant undergo body composition study measure total body fat muscle content use dual-energy x-ray absorptiometry ( DEXA ) scan . During third evaluation , participant undergo electrocardiogram ( ECG ) echocardiogram ( ECHO ) , perform immediately walk treadmill . The ECG measure electrical activity heart , ECHO involve image heart ultrasound . Visits 2 3 , occur 3 day apart , include two imaging test heart : positron-emission tomographic ( PET ) scan rest ECHO . Throughout test ECG blood pressure cuff use monitor heart rhythm blood pressure , respectively . During PET scan , participant lie flat imaging machine three 45- 60- minute interval . Blood drawn radioactive tracer inject via intravenous line place arm . The ECHO test also do PET scan . Between Visits 2 3 , participant randomly assign one two hormone replacement therapy ( HRT ) regimens : estrogen plus placebo estrogen plus progesterone . All participant wear patch contain estrogen take pill either placebo progesterone 3 day lead Visit 3 . All participant ask permission store sample blood 10 year use future research study .</detailed_description>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy postmenopausal woman Body mass index less 30 Practices normal eat habit Stops hormone replacement therapy least 6 month prior study entry Currently take hormone replacement therapy History cardiovascular disease Family history coronary artery disease Recent history smoking , high blood pressure , hyperlipidemia</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Post-Menopausal</keyword>
	<keyword>PET</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Heart Metabolism</keyword>
	<keyword>Cardiovascular Disease</keyword>
</DOC>